The Food and Drug Administration (FDA) of America has authorized the use of blood plasma from the COVID-19 survivors. It will be used to treat the disease. As stated by the FDA, it can decrease the mortality of the patients as well as improve the health condition if it is used within the first three ..
COVID-19 treatment: GK, General Studies and Current Affairs
On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal antibody that was already approved for chronic plaque psoriasis. The drug will now be used to treat COVID-19 based on clinical trials. The drug was manufactured and ..
The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the second vaccine trial approved by India after Bharat Biotech’s COVAXIN. Highlights The DCGI approved the vaccine trials after the animal trials of the vaccine was satisfactory. The ..
On July 2, 2020, the Union Minister of Health and Family Welfare Dr Harsh Vardhan and Union Minister of HRD Ramesh Pokhriyal launched “Drug Discovery Hackathon”, 2020. Highlights The event was jointly launched by the All India Council for Technical Education (AICTE) and CSIR (Council of Scientific and Industrial Research). The event was inaugurated virtually. ..